Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Oncomfort

Explore full profile

Virtual reality digital sedation for medical procedures

Wavre, BelgiumFounded 2017Health Tech & Medtech
Valuation $50–100M Last recorded · 2020
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Oncomfort and the history behind them.

About Oncomfort

Oncomfort was a Belgian-based developer of a digital sedation device for managing patient pain and anxiety before, during, and after medical procedures. Founded in 2017 by Diane Jooris, Mario Huyghe, and Julien Tesse, the company created a non-pharmacological therapy that combines clinical hypnosis and integrative therapeutic techniques using virtual reality. This approach aimed to reduce the need for medications and improve patient comfort and outcomes.

Co-founder Diane Jooris, who served as Chief Scientific Officer, has a background in clinical psychology and law, and practiced clinical hypnosis at the MD Anderson Cancer Center. Her experience helping cancer patients manage anxiety during invasive procedures inspired her to develop a more scalable, automated tool for hypnotherapy. Co-founder Mario Huyghe, who acted as CEO, has over two decades of experience in the healthcare business and eHealth sectors.

The company's core product, the Sedakit™, was a portable, all-in-one medical device that included a VR headset and provided a library of therapeutic sessions tailored to different patient needs, ages, and medical contexts, available in 12 languages. It was designed for use in various clinical fields, including anesthesia, oncology, interventional radiology, cardiology, and pediatrics. Clinical studies indicated that the digital sedation method could reduce procedure times, decrease involuntary movements, and in 80% of certain orthopedic surgeries, replace the sedative drug midazolam.

In September 2020, Oncomfort secured a €10 million ($11.8M) Series A funding round co-led by Debiopharm and Crédit Mutuel Innovation to advance product development and accelerate international expansion into European and American markets. The company gained a CE mark for its device in June 2018 and, by late 2020, had treated over 60,000 patients. In October 2023, Oncomfort was acquired by HypnoVR, a French competitor in the VR-based medical hypnosis space. The acquisition was intended to consolidate HypnoVR's market leadership in Europe and ensure the continued development and availability of Oncomfort's technology, which is now integrated into HypnoVR's offerings.

Source: Dealroom company data

At a glance

Status
Acquired
Founded
2017
Headquarters
Wavre, Belgium
Employees
1
Open positions
None listed
Dealroom signal
59.1/100
Industry
Health
Sub-industry
Medical Devices, Health Platform
Sector
Health Tech & Medtech, Psychology, Data Analytics, Biotechnology, Mental Health, Immersive Technologies, Digital Therapeutics, Tech for Biotech and Pharma
Technology
Deep Tech, Virtual Reality
Business model
Manufacturing
Client focus
b2b

Funding history

4 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
ACQUISITION✓Exit Oct 2023 $0 — Hypno VR ↗
SERIES A✓Equity / VC Sep 2020 $11M $44M WE Venture · Crédit Mutuel Innovation · Debiopharm Group · Crédit Mutuel Equity ↗
Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Financials

Revenue, earnings and profit over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

YearEBITDAMarginProfitMargin
2026 — —
2025 — —
2024 — —
2023 — —
2022 — —
2021 — —
2020 — —
Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

Oncomfort website traffic

Latest recorded traffic for Oncomfort is 50 monthly website visits, down 95.8% over the last three months. Oncomfort's team declined 75% over the past year.

Latest monthly visits50 3-month web change-95.8% 1-year team growth-75%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

8 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed3 investors entered at this stage

  • Be Angels
  • BAN Flanders
  • WE Venture

Series A3 investors entered at this stage

  • Crédit Mutuel Innovation
  • Debiopharm Group
  • Crédit Mutuel Equity

Other known investors2 additional known investors

  • Hypno VR
  • Caring Entrepreneurship Fund
Team profiled 6 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇧🇪 Belgium100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Oncomfort on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Oncomfort’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.